by Krystal Jacques | Nov 5, 2025
Spinal cord injury, stroke and amyotrophic lateral sclerosis (ALS) are all conditions that can disrupt the critical nervous system pathways responsible for controlling muscles. This frequently leads to a profound loss of motor function, such as weakness or paralysis....
by Lyla El-Fayomi | Jul 17, 2025
The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half....
by Stacey Johnson | Jun 24, 2025
Pink. What does the colour pink make you think of? It might make you think of activism, acceptance, awareness and allyship based on how it has been adopted by various groups around the world. Pink makes me think of the American singer, songwriter and activist P!nk....
by Kevin Robb | May 22, 2025
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from...
by Lyla El-Fayomi | May 16, 2025
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on...
by Laya Kiani | May 8, 2025
We’ve all heard about Bitcoin—the first decentralized cryptocurrency. From overnight millionaires to market crashes, crypto has been a rollercoaster ride. Since 2008, cryptocurrencies have introduced a new era in the financial sector by enabling transactions without...
Comments